<DOC>
	<DOC>NCT00262470</DOC>
	<brief_summary>This trial is designed to study the effects of various mechanistically unique medications in controlling excessive increases in heart rate with standing and in improving the symptoms of orthostatic intolerance in patients with this disorder.</brief_summary>
	<brief_title>Treatment of Orthostatic Intolerance</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Orthostatic Intolerance</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Mecamylamine</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<mesh_term>Indomethacin</mesh_term>
	<mesh_term>Entacapone</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<criteria>Chronic symptoms (&gt; 6 months) with standing upright Obvious cause of hypovolemia or drugs that could worsen tachycardia Chronic severe medical conditions such as cancer or ischemic heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>tachycardia</keyword>
	<keyword>sinus tachycardia</keyword>
	<keyword>postural tachycardia syndrome (POTS)</keyword>
</DOC>